HealthPreparations

"Djakavi" (rusolitinib) price, analogues. Where to buy Giacavi cheaper

The new drug "Djakavi", produced by the Swiss company Novartis, is well-deservedly popular among doctors involved in the treatment of cancer.

Ruxolitinib, which is the main active substance of the said agent, is a protein tyrosine kinase inhibitor. It is effective in the treatment of diseases that are associated with splenomegaly, as well as myelofibrosis (including primary and secondary, developed as a result of essential thrombocythemia and true polycythemia).

Researchers note that the use of the drug reduced the size of the spleen by 35%, increased life expectancy and its quality. In this case, the toxicity of the active substance is moderate, in comparison with other preparations of a similar spectrum of action.

Where can Giacavi tablets buy cheaper?

But before continuing the description of the drug, one can not help saying that the treatment of serious diseases requires a large number of expensive drugs, and this can not but cause concern in patients. It is not possible to refuse vital medicines, but it is often difficult to acquire them. So, in Moscow pharmacies for tablets "Giacavi" the price starts from 100 000 rubles.

The WWW.ONKO24.COM website , where you can buy a generic of the named drug, can come to the rescue in this situation . With the full similarity of the components and the same effect from the application, it will cost much less. The fact is that generic production does not bear the costs for the development, testing and promotion of funds, which allows its producers, working under an official license, to pay back the release of the medicine at a lower cost.

Dosing and Administration

Patients should be aware that the use of the drug "Giacavi" is not dependent on food intake. And if in the prescribed time to drink tablets failed, you can not take their double dose. It is not necessary because of this and shift the time of the next reception.

The initial dose of the described agent is prescribed only by a specialist, depending on blood indices - the number of platelets. As a rule, it is 15 mg (take 2 rivers a day), with a number of 100-200 / nl, and with an amount of more than 200 / nl - 20 mg. If the number of platelets is 50-100 / nl, then the maximum initial dose of the drug should not be more than 5 mg, twice a day. At the same time, the maximum dose, according to the instructions for use applied to the "Giacavi" preparation, should not exceed 25 mg taken twice a day.

In general, in the treatment with ratsolitinib, regular counts of blood cells (erythrocytes, leukocytes and platelets) should be done regularly: every 2-4 weeks during the dose selection period and then depending on the clinical indications.

Contraindications

To use the drug "Giacavi" there are certain contraindications:

  1. Pregnancy and lactation.
  2. The patient's age is less than eighteen years.
  3. Personal intolerance of ratsolitinib or another component of the drug.

According to the experts' comments on the use of "Gakavi", the drug should be used with caution in the treatment of patients who have renal failure or who are on hemodialysis. To the same category are patients with thrombocytopenia, neutropenia and anemia.

Side effects

In the process of application, as indicated in the instructions attached to the "Giacavi" instruction, the following undesirable reactions were most often observed:

  • urinary tract infections;
  • anemia;
  • Neutrophilia;
  • Thrombocytopenia;
  • Bleeding (including bruising, nasal and intracranial hemorrhages, as well as hemorrhage in the digestive tract);
  • Increase in body weight;
  • Dizziness;
  • Hypercholesterolemia;
  • headache.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 en.birmiss.com. Theme powered by WordPress.